Pharmaceuticals Research This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 26.

Wesley Medical Center parent HCA posts Q2 revenue gains
Increased patient volumes and the consolidation of one of its health care entities helped HCA Holdings Inc. post strong revenue numbers in the second quarter of 2012. The Nashville, Tenn.-based company, which is the parent of Wesley Medical Center and Galichia Heart Hospital in Wichita, announced Monday an 11.9 percent increase in revenue over a year ago. HCA’s second-quarter revenue increased to $8.112 billion, from $7.249 billion in the second quarter of 2011. HCA (NYSE: HCA) says the growth…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Josh Heck Source Type: research

Exec VP Ward out at BDSI
Raleigh drug developer BioDelivery Sciences International has terminated the contract of a top executive without cause. The executive, Benny Ward, is a CPA and worked as executive vice president of business and strategic development since September 2010. He will receive a lump sum of $195,000, equal to one year’s salary. In 2011, his total compensation was $236,888. BioDelivery (Nasdaq: BDSI) announced the decision in a regulatory filing late Friday afternoon. The company says it plans to fill…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Jason deBruyn Source Type: research

Challenging Generic Drug Deals
Pharma companies in Europe, U.S. face scrutiny over so-called pay-to-delay tactics.
Source: Chemical and Engineering News - August 6, 2012 Category: Chemistry Authors: Rick Mullin Source Type: research

In vitro studies on the mechanism of action of VEGF and its inhibitors on blood‐retina barrier
Conclusion VEGF is mainly responsible for disrupting the barrier function of REC. This supports VEGF targeting as a therapeutic concept. Independent research grant by Novartis Pharma, Germany
Source: Acta Ophthalmologica - August 6, 2012 Category: Opthalmology Authors: H DEISSLER, G LANG Tags: 4411 Source Type: research

Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET
Conclusion These preclinical findings suggest that clinical PET imaging is a useful tool for early response monitoring in clinical studies. Content Type Journal ArticleCategory Research ArticlePages 1-9DOI 10.1007/s11307-012-0580-0Authors Stefan Wiehr, Department of Preclinical Imaging and Radiopharmacy, Laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens-Foundation, Eberhard Karls University Tübingen, Tübingen, GermanyOliver von Ahsen, Bayer Pharma AG, Berlin, GermanyLars Röse, Bayer Pharma AG, Berlin, GermanyAndre Mueller, Bayer Pharma AG, Berlin, GermanyJulia G. Mannhei...
Source: Molecular Imaging and Biology - August 3, 2012 Category: Molecular Biology Tags: Molecular Imaging and Biology Source Type: research

MRIGlobal gets $3.8M contract to study cancer drugs
The National Cancer Institute has awarded MRIGlobal a five-year, $3.8 million contract to analyze potential drugs in the fight against cancer. Kansas City-based MRIGlobal announced the award Friday, saying this is the 12th consecutive contract from the NCI for the Anti-Cancer Chemicals and Pharmaceutical Formulations Analysis Program. The program deals with bulk pharmaceutical substances and drugs, typically before they’re approved by the U.S. Food and Drug Administration. During the past 43…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: David Twiddy Source Type: research

GlaxoSmithKline completes Human Genome Sciences takeover
GlaxoSmithKline PLC has completed its $3.6 billion takeover of Rockville-based Human Genome Sciences Inc., the final step in a months-long struggle for control of the company. All outstanding shares of Human Genome were acquired for $14.25 per share in cash. Human Genome Sciences agreed last month to be acquired after earlier rejecting an acquisition offer of $13 per share as too low. Glaxo has said the acquisition will add to earnings starting in 2013 and will result in $200 million in cost savings…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Jeff Clabaugh Source Type: research

Globus Medical sets IPO at $12 a share
Globus Medical Inc. said Friday it is pricing its initial public offering of 8.3 million shares of common stock at $12 per share. The $100 million offering, according to the Audubon, Pa., spinal implant products manufacturer, consists of 2.08 million shares being offered by Globus Medical and 6.25 million shares being offered by selling stockholders. Closing of the offering is expected to occur on Aug. 8 subject to customary closing conditions. The shares are expected to begin trading on the New…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: John George Source Type: research

UT Southwestern gets $48M in cancer research grants
Investigators at UT Southwestern Medical Center in Dallas have been awarded more than $48 million in cancer research grants by the Cancer Prevention Research Institute of Texas. The Institute was established in 2007 by Texas voters who approved a constitutional amendment to authorize the state to pay for cancer research and prevention programs, according to a release. The latest grants will cover research in colon, breast and prostate cancers among others, the Institute said. Here's how the $48…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Source Type: research

Earnings: Cumberland Pharmaceuticals down 19.5% in Q2
Cumberland Pharmaceuticals Inc.'s (Nasdaq: CPIX) earnings were down 19.5 percent in the second quarter compared to one year ago. Earnings were $1.7 million, or 9 cents per share, on revenue of $12.4 million. Analysts, on average, had anticipated earnings of 7 cents per share on revenue of $12.6 million, according to Thomson Reuters. "As we reach the halfway point in 2012, we are beginning to see the impact of the new commercial strategy that was announced earlier this year," said A.J. Kazimi, CEO…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Eric Snyder Source Type: research

Two Houston companies receive Texas Emerging Technology Fund awards
Rebellion Photonics and Vapogenix Inc. have been selected to receive awards from the Texas Emerging Technology Fund, Gov. Rick Perry said Friday. Houston-based Rebellion Photonics is receiving $250,000 of a committed amount of up to $1 million to develop its Gas Cloud Imager. The device detects leaks in oil industry activities through a video camera that can identify the chemical composition of a gas cloud in real time. Houston-based Vapogenix Inc. is receiving $1 million of a committed amount…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Olivia Pulsinelli Source Type: research

ED GOLDMAN: Helping victims of abuse
When Elaine Whitefeather, executive director of the Domestic Violence Intervention Center, calls herself “a person of color,” it’s one of her rare moments of understatement. Her father was Native American (of the Lakota tribe), African-American and German. Her mother was Japanese. When I suggest she’s more like a person of “colors” she roars with laughter. The reaction is more than my quip deserves, but Whitefeather is simply one of those people you meet along the way who’s full of…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Ed Goldman Source Type: research

Advanced Liquid Logic raises $1M
Morrisville-based Advanced Liquid Logic has secured $1 million with $2 million still left to go in its latest round of fundraising. The equity sum came from a single investment and the goal, according to an SEC filing, is to raise the full sum by the end of the month. The fundraising is happening as Advanced Liquid Logic prepares to move its diagnostics research into the commercial space. ALL creates what it calls a “lab on a chip,” where a single drop of blood can diagnose a condition. In…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Lauren K. Ohnesorge Source Type: research

Orlando Health performs its first TAVR procedure
The Orlando Health Heart Institute has performed its first trans-aortic valve replacement procedures, the hospital announced August 3. The hospital, which announced they would be doing the procedure in March, has performed a total of three procedures – two on July 23 and one on July 30. The TAVR procedure inserts a small artificial heart valve through an artery in the groin. The valve is threaded to the narrow valve and expanded, pushing the narrow, calcified valve out of the way. The Food and…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Abraham Aboraya Source Type: research

BizNext: 7 things you need to know today 8.3.2012
Boeing Co. and Space Exploration Technologies Corp. expect to win the bulk of as much as $1 billion in federal awards today to spur development of next-generation manned spacecraft. A cybersecurity bill with bipartisan support and backing by the White House and the national security establishment was blocked by a Republican filibuster in the Senate yesterday. The bill would have put in place voluntary security standards for private companies to follow. Republic opponents argued even voluntary security…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Amir Kurtovic Source Type: research

MedTrak Services acquisition adds 10,000 clients
MedTrak Services LLC has purchased the pharmacy benefits management business (PBM) of Pharmacy First, adding around 10,000 clients. In a joint release Thursday, the two Overland Park-based companies announced the acquisition of BeyondRx, Pharmacy First’s PBM subsidiary, for an undisclosed price. Pharmacy First said it is focusing on its core business of providing third-party services to independent pharmacies. Bob Dill, vice president of operations, said in the release that it was drawn to MedTrak…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: David Twiddy Source Type: research

Kindred posts 2Q profit of $15.5 million
Kindred Healthcare Inc. reported second-quarter net income of $15.5 million, or 29 cents per share. A year earlier, the company had a net loss of $5.5 million, or 13 cents per share. Second-quarter revenue rose to $1.53 billion from $1.29 billion a year earlier. A consensus of analysts surveyed by research firm Thomson Financial called for the company to post second-quarter earnings of 37 cents a share. Louisville-based Kindred Healthcare (NYSE: KND) provides health care services at 2,142 locations,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: David A. Mann Source Type: research

Multnomah County takes library district to voters
Multnomah County’s Board of Commissioners has unanimously sent a measure to voters that would change the way the county funds its libraries. The strategy would establish a permanent library tax district that replaces the need for temporary funding levies to be passed for library programs. Under the district, residents would pay a permanent rate of $1.24 per $1,000 of a property’s assessed value. By establishing a library district, the county would raise at least $58.5 million. The temporary…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: Andy Giegerich Source Type: research

Transwestern brings on Megan Sherwood to head health care division in Phoenix
Transwestern, a privately-held commercial real estate investment and development firm based in Houston, has hired Megan Sherwood as senior vice president of Transwestern’s Phoenix health care advisory team. Sherwood assumed her new post this week after a 14-year tenure at The Plaza Companies in Peoria, where she most recently served as senior vice president of leasing and sales and focused on medical and office space, Transwestern said in a company statement. Sherwood has 25 years of real estate…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: Adam Kress Source Type: research

Highwoods stock offering to fund acquisition of Greensboro medical buildings
Highwoods Properties Inc. will issue 66,828 corporate units convertible into common stock and valued at nearly $2.3 million as part of its acquisition of a complex of Greensboro medical buildings. Highwoods (NYSE: HIW) announced the purchase in July, saying it had bought two buildings and planned to complete the purchase of a third by the fall. The total price tag for the 149,000 square feet of office space plus a parking deck was put at nearly $30 million. The buildings are on North Church Street…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: Lee Weisbecker Source Type: research

BioDelivery Sciences ready to launch new drug trial
Raleigh’s BioDelivery Sciences is ready to launch a Phase III trial for its lead drug candidate, something that could net the company $30 million in milestone payments. If the trials show promising results — by no means a guarantee — BioDelivery (Nasdaq: BDSI) would almost certainly file a New Drug Application with the U.S. Food and Drug Administration. That would trigger milestone payments from Chadds Ford, Pa.-based Endo Pharmaceuticals (Nasdaq: ENDP), BioDelivery’s partner in developing…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: Jason deBruyn Source Type: research

California health care reform goes into overdrive
The U.S. Supreme Court decision to uphold most of the Affordable Care Act hasn’t changed much in California — except to put the reform effort into overdrive. While the National Federation of Independent Business remains undeterred from efforts to unwind the law, health industry experts who spoke on a Business Journal panel Thursday see the court decision as a catalyst that will escalate change. “We’re on a burning platform with a medical rescue system that does a good job repairing folks,”…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research

Confused about health care reform? We've got answers
Understand all the ins and outs of health care reform? How it will affect you and your business? No? Don’t worry, we’ve got your back. The Business Journal will hold a breakfast panel discussion Aug. 10 starting at 7:30 a.m. at the Marriott at Piedmont Triad International Airport. The panel will feature some of the Triad’s most knowledgeable executives in areas including health care, accounting, insurance and law. The discussion will focus on what your should be doing to prepare. We’d…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: Mark Sutter Source Type: research

PharMerica’s 2Q net income little changed
Louisville-based PharMerica Corp.’s second-quarter net income rose slightly, to $7.6 million, or 26 cents per share, from $7.4 million, or 25 cents per share, a year earlier. Revenue for the quarter declined to $458.5 million from $531.7 million. A consensus of analysts surveyed by research firm Thomson Financial called for the company to post second-quarter earnings of 30 cents a share. PharMerica (NYSE: PMC) is a national provider of institutional pharmacy and hospital pharmacy management…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: David A. Mann Source Type: research

Gilead, Indian drugmakers partner on HIV medicine
Gilead Sciences Inc. said Thursday it has a new agreement with three Indian pharmaceutical companies it hopes will give people in developing countries access to low-cost generic versions of Gilead’s HIV medicines. Foster City-based Gilead (NASDAQ:GILD) agreed to license some of its HIV drug technology to Mylan Laboratories, Ranbaxy Laboratories Ltd. and Strides Arcolab in India. Gilead will also provide funding to help the generic drug makers improve their manufacturing processes and reduce costs. The…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 2, 2012 Category: Pharmaceuticals Authors: Diana Samuels Source Type: research

Hawaii Life Flight to star in new series on The Weather Channel
The crew and operations of Hawaii Life Flight, which provides air ambulance services in the Islands, will be showcased in a new documentary series on The Weather Channel starting in September. The series, tentatively entitled “Hawaii Air Rescue,” will focus on the work and personal lives of Hawaii Life Flight’s employees. According to Jeanette Kawakami, director of business development at Hawaii Life Flight, the series will bring attention to a service that is “crucial” to Hawaii. “We…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 1, 2012 Category: Pharmaceuticals Authors: Casey Tong Source Type: research

Colorado jury awards record $15M in medical malpractice case
A jury in Colorado Springs has returned a verdict of $15 million in a medical malpractice case filed against Memorial Health System and a local doctor. It’s the largest medical malpractice verdict on record in Colorado, according to Jury Verdict Reporter of Colorado, which has records of federal and district cases in the state going back to the mid-1980s. Denver attorney David S. Woodruff, of Hillyard, Wahlberg, Kudla, Sloane & Woodruff, served as lead counsel in the case. He represented Jason…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 1, 2012 Category: Pharmaceuticals Authors: Heather Draper Source Type: research

DaVita sees revenue, adjusted earnings rise
DaVita Inc. increased its year-over-year net revenues in the second quarter of 2012 and also saw adjusted earnings rise, the Denver-based dialysis center operator reported Wednesday. Net operating revenue rose to $1.93 billion in the quarter from $1.66 billion in the same period of 2011, according to a statement from the company. Q2 unadjusted net income attributable to DaVita (NYSE: DVA) declined to $95.3 million, or 99 cents a diluted share, from $100 million, or $1.03 a share, in the year-ago…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 1, 2012 Category: Pharmaceuticals Source Type: research

Smith sets money, donor-type limits
Portland mayoral hopeful Jefferson Smith said he plans to keep his average campaign donation less than $200 “going forward.” Smith, who’d griped July 23 that general election opponent Charlie Hales had jumped the gun on joint campaign finance limits, also said he’ll accept no donation higher than $1,000 and pledged to keep his general election spending limit at $500,000. “This general election should not cost over $1 million,” Smith wrote in a message on his website. “Should the other…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 1, 2012 Category: Pharmaceuticals Authors: Andy Giegerich Source Type: research

Topical tacalcitol ointment can be a good therapeutic choice in erythromelanosis follicularis faciei et colli
To the Editor: Erythromelanosis follicularis faciei et colli (EFFC) is an uncommon erythematous pigmentary disorder involving hair follicles with unknown origin. It predominantly affects preauricular and maxillary regions and many therapeutic options have been tried. However, the results were variable and the treatment of EFFC is still challenging. Tacalcitol is a synthetic analog of vitamin D3 and its successful treatment in psoriasis and other keratinization disorders such ichthyosis, Darier disease, and keratosis pilaris has been reported. As it is known that many patients with keratosis pilaris have concomitant EFFC in...
Source: Journal of the American Academy of Dermatology - August 1, 2012 Category: Dermatology Authors: Won-Jeong Kim, Margaret Song, Hyun-Chang Ko, Byung-Soo Kim, Moon-Bum Kim Tags: Research Letters Source Type: research

Strategic alliances and market risk.
Abstract Strategic alliances in product development and marketing are crucial to the biotechnology industry. Many alliances, however, are terminated before the drug reaches the market. In this article we make the case that strategic alliances can fail because of how they are negotiated. Alliance contracts are often inflexible and do not allow for changes in market conditions. We propose a model for contract valuation that can assist biotech and/or pharma deal makers in negotiating alliances that have a higher chance of survival in uncertain market conditions. The model makes use of variable royalties and milestone ...
Source: Drug Discovery Today - August 1, 2012 Category: Drugs & Pharmacology Authors: Havenaar M, Hiscocks P Tags: Drug Discov Today Source Type: research

Parkinson Research Foundation, USF to open new center
The Parkinson Research Foundation and the University of South Florida will open a center for patients, caregivers and health care providers connected to Parkinson’s disease. The center, called Parkinson Place, will open Sept. 5 in Sarasota. It will offer a variety of education, empowerment and participation programs in an environment where people with Parkinson’s can be engaged, a written statement said. Dr. Juan Sanchez-Ramos, who holds the Helen Ellis Endowed Chair for Parkinson’s disease…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Source Type: research

PolyMedix using NIH grant to develop malaria treatments
PolyMedix Inc. has received the second phase of a National Institutes of Health grant, which is providing the Radnor, Pa., biopharmaceutical company with up to $1 million per year for three years to support the development of its defensin-mimetic antimicrobial compounds for the treatment of malaria. This grant will continue to fund PolyMedix’s (OTCBB:PYMX) collaborative work with Dr. Doron Greenbaum, an assistant professor of pharmacology at the University of Pennsylvania, “Resistance has developed…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Authors: John George Source Type: research

CryoLife Q2 profit grows 83%
CryoLife Inc. (NYSE: CRY) The Kennesaw, Ga.-based implantable biological medical device and cardiovascular tissue processing company saw a big jump in second-quarter profit, boosted in part by expense management and revenue growth. Revenue: $33.2 million, up 13 percentNet Income: $3.3 million, up 83.3 percentEarnings Per Share: 12 cents, up 100 percent Click here for the full earnings report. Steven G. Anderson, president and CEO: “Total revenue was up 13 percent year-over-year, driven by…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Authors: Jacques Couret Source Type: research

Clark Construction to build Inova hospital in Fairfax
Clark Construction Group has been selected by Inova Health System to build a 665,000-square-foot women and children's hospital, Virginia Business reports. The $215 million contract to the Bethesda-based construction firm is part of Inova’s efforts to upgrade its Fairfax campus, and it represents the largest phase of a capital improvement program. The 12-story hospital will include 192 patient rooms on four floors, a 108-bed neonatal intensive care unit, 33 labor and delivery rooms and eight operating…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Source Type: research

MedStar will fund major upgrade at Southern Maryland Hospital
MedStar Health will spend "well over $100 million" over the next five years to upgrade Southern Maryland Hospital Center once its purchase of the 35-year-old facility closes later this year, executives said Monday after announcing the deal. MedStar's plans include a new outpatient center on the hospital campus off Surratts Road in Clinton, as well as extensive renovations to the main hospital, Southern Maryland CEO Michael Chiaramonte said in an interview. Hospital officials hope to seek regulatory…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Source Type: research

MedStar now profitable, well positioned in Prince George's County
In announcing plans to buy Southern Maryland Hospital Center, MedStar Health strikes a major blow in the the ongoing battle with the state's other major health providers for market supremacy. In addition to being profitable, the 238-bed facility in Clinton has long held a crucial strategic position in the geography of health care, bridging the rural reaches of southern Maryland with the Washington area's core. But since 2009, it's taken on added importance as large systems from the Baltimore-Washington…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Source Type: research

GenSpera gains FDA approval to proceed with Phase II of prostate drug
The Food and Drug Administration has cleared GenSpera Inc. to proceed with Phase II clinical trials of its lead investigational drug, G-202, for the treatment of prostate cancer in patients who have failed prior hormonal therapy. The Phase II study will be conducted at up to six sites in the United States and the United Kingdom and will involve up to 40 patients. San Antonio-based GenSpera (OTCBB: GNSZ) has already conducted a Phase I clinical trial of G-202 at the Sidney Kimmel Comprehensive Cancer…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Authors: James Aldridge Source Type: research

AmerisourceBergen gets Cardinal’s contract with Express Scripts
AmerisourceBergen Corp. announced a three-year agreement Tuesday to supply about $18.5 billion in pharmaceuticals annually to Express Scripts’ recently combined mail-order and specialty-pharmacy businesses. AmerisourceBergen shares were trading 3.9 percent higher at $40.02. The agreement is effective Oct. 1. Express Scripts’ supply deal with Cardinal Health (NYSE:CAH) expires Sept. 30. Cardinal shares were up less than 1 percent at $43.62. Officials at AmerisourceBergen (NYSE:ABC) said the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Authors: John George Source Type: research

Piedmont CEO Tim Stack dies
Piedmont Healthcare CEO R. Timothy Stack died Monday. Stack, 60, captained the five-hospital health system for more than a decade. Piedmont’s President of Finance and Development Greg Hurst — the health system’s second highest executive — will continue to handle the duties of CEO, as he has since Stack went on medical leave in early June. Stack’s passing comes as Piedmont Healthcare is locked in a market share battle with cross-town rival Emory Healthcare. Piedmont beat Emory for control…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Authors: Urvaksh Karkaria Source Type: research

23andMe seeks FDA clearance of DNA analysis test
Consumer genetic testing company 23andMe Inc. submitted paperwork to the Food and Drug Administration for clearance of its personal genome service, it said Monday. It is the first step toward 510(k) clearance for medical devices, the Mountain View company said on its "The Spittoon" blog. The company also said it believes it is the first direct-to-consumer genetic testing service to publicly acknowledge that it is trying to win FDA clearance. The company uses a saliva sample, which consumers supply…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2012 Category: Pharmaceuticals Source Type: research

Debt collector Accretive Health banned from Minnesota
Accretive Health Inc. has been banned from doing business in Minnesota for up to six years and must pay $2.5 million to the state under a settlement over allegations it used unethical tactics to collect money from Fairview hospital patients. Chicago-based Accretive must cease doing business in the state by Nov. 1, Minnesota Attorney General Lori Swanson said in a news release Monday. It is banned from doing business in Minnesota for at least two years and as many as six. The agreement allows the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: Ed Stych Source Type: research

Gates Foundation grants $110K to Israeli company for waterless toilet
The Bill & Melinda Gates Foundation awarded a $110,000 grant to an Israeli company for the development of a new toilet that doesn’t require water and recycles the waste. The Gates Foundation awarded the grant to Paulee CleanTec as part of the Seattle-based foundation's efforts to “create the next generation sanitation technology.” Hebrew University biotech professor Oded Shoseyov invented the process for the toilet based on a technology created by Oded Halperin, one of Paulee’s original…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: Valerie Bauman Source Type: research

Humana 2Q earnings decline, miss estimates
Humana Inc.’s net income for the second quarter fell to $356 million, or $2.16 per share, diluted, from $460 million, or $2.71 per share, diluted, a year earlier. The figure for the latest quarter included 18 cents per share in expenses related to the previously disclosed settlement of a litigation matter. Revenue for the quarter rose 4.5 percent from a year earlier, to $9.69 billion from $9.28 billion. Earnings per share were below the estimate of $2.28 predicted by a consensus of analysts…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: David A. Mann Source Type: research

Christus relocates elderly care unit to medical center
Christus Santa Rosa Hospital - Medical Centre has become the new home for the inpatient Acute Care for the Elderly. Christus officials relocated the unit from its City Centre downtown hospital to the medical center hospital campus. The unit relocated due to the planned closure of the downtown hospital. As previously reported, Christus is in the midst of a $135 million transformation of its downtown hospital into a children’s hospital. The unit provides a complete geriatric assessment for patients,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: James Aldridge Source Type: research

Teleflex confirms plans for Olive Branch facility
Teleflex Inc. confirmed plans it would be relocating a distribution operation to Olive Branch, employing 225 within four years. The Limerick, Pa.-based medical devices company is moving into 627,000 square feet at 11244 Distribution Cove, as reported in the July 6-12 edition of Memphis Business Journal. “A single, centralized distribution facility will generate improved operating efficiencies and improved customer service, and we look forward to being here for many years to come,” Benson Smith,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: Andy Ashby Source Type: research

NM Health Connections rounds out executive team
New Mexico Health Connections, the state’s startup nonprofit health plan, has added three health care professionals to its executive team. With more than 80 years of combined health care experience, the three will give the health plan a “strong start,” NMHC CEO Dr. Martin Hickey said in a news release. The three are: Anne Brennan Sapon, director of operations. Sapon has more than 20 years of health care experience. She has worked as an independent health care consultant, president of operations…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: Dennis Domrzalski Source Type: research

METCO approves three loans worth $225,000 total
The Louisville Metropolitan Business Development Corp., or METCO, has approved loans worth a total of $225,000 to three small businesses. The loans were expected to leverage $2.2 million in total investment, according to a news release from the office of Louisville Mayor Greg Fischer. The three loans made were to the following businesses: • Shepherds Care Memory Home LLC, 8802 Smyrna Parkway, $100,000 loan to enable owner Mark Hegele to open an 18-room assisted-living facility for Alzheimer’s…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: Kevin Eigelbach Source Type: research

Univera, Unigen move into former Dendreon space
Two sister companies that develop and sell nutritional products have relocated their headquarters from Lacey to Seattle’s Belltown neighborhood. Univera, a nutritional supplements company, and Unigen, a research and development firm, now occupy approximately 70,000 square feet of space at 3005 1st Ave. The space was previously occupied by publicly traded Seattle biotech Dendreon. Bill Lee, chairman of parent company Econet, said in a release that the relocation was prompted by the firms’ desire…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Authors: Jeanne Lang Jones Source Type: research

Mednax buys 16-office practice in Tennessee
Mednax bought Anesthesia Medical Alliance of East Tennessee, which has 16 locations across its state. The Sunrise-based medical practice ownership company (NYSE: MD) paid cash for the Knoxville-based medical group, but did not disclose how much. The practice will be the first Tennessee member of Mednax’s American Anesthesiology division. AMAET has 45 anesthesiologists and 158 anesthetists. It serves five hospitals. Mednax has acquired eight medical practices this year, with half in anesthesiology…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2012 Category: Pharmaceuticals Source Type: research